Long-Term Use of Actonel, Boniva, Fosamax and Reclast Linked to Hip-Fractures

Two new studies recently indicate that certain osteoporosis drugs, which are supposed to strengthen bones and protect people from fractures, are actually increasing the risk of spine and hip fractures if taken for more than five years. These bisphosphonate drugsare some of the most widely prescribed drugs in the world.

The chief of metabolic bone disease at the Hospital for Special Surgery in New York / presented research at the annual conference of American Academy of Orthopedic Surgeons in New Orleans, indicating that if these medications are taken for more than five years, healthy, active women are at an increased risk of suffering atypical hip fractures of the femur.

Although these drugs seem to be effective at strengthening bones and preventing fractures for a short time period, after extended use, they can cause some people to have diminished quality of the bone. Research shows that the fractured bones were indicative of old bone mass, not the normal distribution of young, middle-aged, and old bone, which creates a stronger, healthier combination, less likely to break.

The research also noted that bone dexascan (DXA)/ showed the potential for a buckling in the femur area of the hip in patients treating for osteoporosis with bisphosphonates, particularly in patients who had been on the drugs for four years or more. The researchers described their findings as lack of quality, not quantity of bone mineral.

Bisphosphonates are among the top-selling drugs in the United States, according to IMSA health, a research firm that tracks prescriptions. Their tally ranks the drugs’ revenue as over $3.5 billion.

If you have suffered a fracture as a result of taking these drugs for several years, please contact Pogust, Braslow & Millrood.